Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY2 | P41231 | 11/20 | 0.76 |
| ▸ | P2RY6 | Q15077 | 14/20 | 0.72 |
| ▸ | P2RY4 | P51582 | 7/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18785149 | 1.00 | P2RY2 (0.76) | P2RY2P2RY6P2RY4 | |
| SCHEMBL12595472 | 1.00 | P2RY2 (0.76) | P2RY2P2RY6P2RY4 | |
| SCHEMBL308618 | 1.00 | P2RY2 (0.76) | P2RY2P2RY6P2RY4 | |
| SCHEMBL18785150 | 1.00 | P2RY2 (0.76) | P2RY2P2RY6P2RY4 | |
| SCHEMBL532547 | 1.00 | P2RY2 (0.76) | P2RY2P2RY6P2RY4 | |
| SCHEMBL154172 | 1.00 | P2RY2 (0.76) | P2RY2P2RY6P2RY4 | |
| SCHEMBL29360821 | 1.00 | P2RY2 (0.76) | P2RY2P2RY6P2RY4 | |
| SCHEMBL18785151 | 1.00 | P2RY2 (0.76) | P2RY2P2RY6P2RY4 | |
| SCHEMBL10585778 | 0.99 | P2RY2 (0.75) | P2RY2P2RY6P2RY4 | |
| SCHEMBL22635992 | 0.99 | P2RY2 (0.75) | P2RY2P2RY6P2RY4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 258 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4686760-A1 | SIALYLTRANSFERASES FOR THE SYNTHESIS OF SIALYLATED GLYCANS, GLYCOCONJUGATES AND GLYCOPROTEINS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2026-02-04 | — | — | EP | claimed |
| US-12378579-B2 | Method to produce the anti-microbial diterpenoid leubethanol and related serrulatane-type diterpenes | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2025-08-05 | — | — | US | claimed |
| WO-2025072741-A1 | PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-04-03 | — | — | WO | claimed |
| CN-117881685-A | Process for producing cytidine-5' -biphosphoric acid compound | 协和发酵生化株式会社 | 2024-04-12 | — | — | CN | claimed |
| CN-117399072-A | Ultra-small cerium-based metal organic framework nano enzyme and preparation method and application thereof | 华南理工大学 | 2024-01-16 | — | — | CN | claimed |
| US-20230193328-A1 | METHOD TO PRODUCE THE ANTI-MICROBIAL DITERPENOID LEUBETHANOL AND RELATED SERRULATANE-TYPE DITERPENES | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY | 2023-06-22 | — | — | US | claimed |
| US-20140004562-A1 | REVERSIBLY WATER-SOLUBLE NANOCRYSTALS | EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2014-01-02 | — | — | US | claimed |
| US-8551452-B2 | Uridine dietary supplementation compliance methods and use thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2013-10-08 | — | — | US | claimed |
| WO-2013107041-A1 | REVERSIBLY WATER-SOLUBLE NANOCRYSTALS CAPPED BY NUCLEOTIDES AND/OR NUCLEOSIDES | EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2013-07-25 | — | — | WO | claimed |
| US-20130045475-A1 | 2-Nitrobenzyl-Modified Ribonucleotides | ALERE SAN DIEGO, INC. (US) | 2013-02-21 | — | — | US | claimed |
| US-20050136673-A1 | CMP slurry | XU WEN-QING (US) | 2005-06-23 | — | — | US | claimed |
| US-20050028450-A1 | CMP slurry | XU WEN-QING (US) | 2005-02-10 | — | — | US | claimed |
| WO-2003072066-A2 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF GLAUCOMA AND OCULAR HYPERTENSION | INSPIRE PHARMACEUTICALS, INC. (US) | 2003-09-04 | — | — | WO | claimed |
| EP-1005327-A1 | TARGETED LIPOSOMAL CONSTRUCTS FOR DIAGNOSTIC AND THERAPEUTIC USES | SDG, INC. (US) | 2000-06-07 | — | — | EP | claimed |
| US-6063400-A | CARRIER; DIAGNOSTIC OR THERAPEUTIC AGENT AND SEQUESTERING AGENT | SDG, INC. (US) | 2000-05-16 | — | — | US | claimed |
| WO-1999001110-A1 | TARGETED LIPOSOMAL CONSTRUCTS FOR DIAGNOSTIC AND THERAPEUTIC USES | SDG, INC. (US) | 1999-01-14 | — | — | WO | claimed |
| US-5770407-A | Process for preparing nucleotide inhibitors of glycosyltransferases | THE SCRIPPS RESEARCH INSTITUTE (US) | 1998-06-23 | — | — | US | claimed |
| EP-0355016-B1 | Process for the preparation of cytidine 5'-diphosphate alkanols and glycerols | CLARION PHARMACEUTICALS INC (US) | 1994-02-09 | — | — | EP | claimed |
| EP-0577266-A2 | Method for preparing (gamma-32p) labeled nucleotides by enzymatic conversion of dihydroxyacetone phosphate to 3-phosphoglycerate | ICN BIOMEDICALS INC. (US) | 1994-01-05 | — | — | EP | claimed |
| WO-1988009171-A1 | PHOSPHOETHANOLAMINE FOR TREATMENT OF ALZHEIMER'S DISEASE | BAYLOR COLLEGE OF MEDICINE (US) | 1988-12-01 | — | — | WO | claimed |